ADME 2 Flashcards

1
Q

What processes govern the onset of drug action and the peak intensity of Response?
- which determine the duration of action?

A

Onset and Peak Intensity Determined by:

  • Absorption
  • Distribution

Duration of Action Determined by:

  • Metabolism and Excretion (which eliminate the drug)
  • They do this by controlling the RATE of TERMINATION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is biotransformation?

A
  • The chemical modification of xenobiotics (non-natural substances) by endogenous enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is metabolism?

A

Chemical Transformation of both Endogenous and Exogenous Agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What do biotransformative and metabolic reactions tend to do to a drug?

A
  • Convert the Active compound into the Less active compounds
  • Convert them to more polar and less lipid soluble forms that favor drug excretion

**These reactions are meant to detoxify and reduce activity but sometimes they do just the opposite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What kinetics describe Metabolic reactions?

A

Michaelis Menton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What component determines reaction rate if:

  • Enzyme is saturated with substrate
  • Substrate is limited
A
  • Reaction is proportional to the level of enzyme at saturating substrate concentrations
  • Reaction is proportional to the substrate if the substate is limiting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are phase I and Phase II Metabolic Reaction?

- consequences of each?

A

Phase I:

  • Add or Unmask functional groups (-OH, -NH2, or -SH) to make the drug more soluble
  • *Often result in reactive (free radical) and potentially Toxic products

Phase II:

  • Covalent addition of functional group to parent compound or to product of the Phase I reaction (e.g. glucuronic acid, glutathione, amino acids, acetate)
  • *Generally make the compound inactive and lead to excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens to morphine in phase II reactions?

A
  • It gets converted to 6-glucuronide metabolite of moriphine and becomes an even more potent analgesic
  • This is the exception not the rule
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

On the Tissue and Subcellular Level where do most Biotransformative reactions take place?

A

Tissues/Organs:

  • Liver
  • G.I.
  • Kidneys
  • Lungs
  • Brain

Subcellular:

  • Endoplasmic Reticulum
  • Cytosol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where do most phase I reactions take place?

- phase II reactions?

A

Phase I: Endoplasmic Reticulum

Phase II: Cytosol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phase I reaction types?

A
  • Redox (O –> =O; -N=N- or NO2 –> NH2)

- Hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phase II Reaction Types?

  • what is the main type?
  • Where does it occur?
A

Glucuronidation:
MAIN CONJUGATION rxn
Occurs in LIVER
UDP-Glucoronsyl Transferases (UGTs) catalyze rxn

Acylation addition
e.g. Sulfonamides

Glycine addition
e.g. Nicotinic Acid

Sulfate (sulfoxidation)
e.g. Morphine and paracetamol

Glutathione (GSH)
- Conjugation of GSH (glutamate-cysteine-glycine) leading to a MERCAPTURIC acid metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Phase II reactions typically make drugs more water soluble (less lipophilic). What is the exception?

A

Acylation often makes things more lipophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does it mean to say something is a microsomal or nonmicrosomal reaction?

A

Microsomal - Takes place in the endoplasmic reticulum

Non-Microsomal - Takes place in the cytosol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the major catalyst of phase I reactions?

  • where are these found?
  • What is the general name given to these catalysts?
A

P450 monooxygenases
Found in the smooth endoplasmic reticulum of lots of tissues with the highest concentration in the liver

**Often referred to as the mixed function oxidase system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which P450 genes encode the majority of biotransformations?

- which is most active in the GI tract?

A

CYP1, CYP2, CYP3

CYP3A4 and CYP3A5 subfamily in the GI tract decreases the bioavailability of many drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does a cytochrome-P450 enzyme complex consist of and reaction does it do?

A

Consists of:

  • cytochrome P450 Enzyme
  • cytochrome P450 Reductase

Rxn:

  • O2 is used and 1 O gets added to the Substrate, the other O gets reduced to H2O
  • IT uses NADPH to do this (no ATP required)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is induction?

- what can it lead to?

A

Drug Induced Change in metabolism

  • Drugs can cause an increase in Liver enzyme activity over time which increases the rate at which drugs are metabolized (even ones other than the one causing induction)
  • this means you will have to increase the dose to get the same effect of the drug and the enzyme you induce may work on other drugs too.
19
Q

What is the time scale for induction?

- can it be reversed?

A

Induction is Reversible

  1. Onset - 3-12 hours
  2. Maximal - 1-5 days
  3. Persistence - 5-12 days
20
Q

What is inhibition?

A

Drug-Induced Change in Metabolism

  • Drugs inhibit the metabolism of other drugs (competitive inhibition)
    (e. g. Warfarin can inhibit Tolbutamide elimination which leads to Tolbutamide conc. being higher in the blood)
  • You’ll need to adjust the dose downward when this happens
21
Q

What is pharmacogenetics?

A

The genetic basis for differences among the population in drug responses (therapeutic or toxic)

22
Q

What is pharmacogenomics?

A

Application of genomic information towards the discovery/development of novel specific drugs.

e.g. drugs that can be targeted for specific use among specific patient populations

23
Q

What is the consequence of pharmacogenetics and pharmacogenomics on physician responsibility?

A

Physician is more responsible for knowing which drug to give to which patient

24
Q

How do genetic polymorphisms factors into pharmacogenomics?

- where are polymorphisms seen to play the biggest role?

A

If a drug is designed to work on the gene product of a polymorphic gene then there is a much greater chance that the drug will have different effects based on different structural characteristics of that protein

Greatest Effects are seen between people of different gender (and between different species).

25
Q

Genetic Polymorphism in Drug Metabolizing enzymes are considered silent until when?

A

These are silent until the patient is challenged by the drug

26
Q

What is the difference in monogenic and polygenic traits graphically?

A

Monogenic traits:
- Usually show two distinct humps

Polygenic traits:
- usually have one large slope

Why:

  • if the trait is influenced by a single gene then its more likely to show sharp variation between individuals who posses differences
  • if the trait has several genes causing an overall phenotypic expression then its less likely to be affected by a polymorphism in a trait
27
Q

What are some possible routes of drug excretion?

A
  • Renal - urine
  • Liver/Intestines - Feces
  • Lungs - Inhaled agents
  • Sweat (minor)
  • Saliva (minor)
  • Breast Milk
28
Q

What 3 major processes occur in the kidney that aid in Renal Excretion?

A
  1. Glomerular Filtration
  2. Tubular Secretion
  3. Tubular Reabsorption
29
Q

How much of the cardiac output is received by the kidneys?

- how fast is this blood filtered (aka Glomerular Filtration Rate (GFR)) ?

A

20-25%

- Blood is filtered by the glomeruli at a rate of 110 to 130 ml/min

30
Q

T or F: Glomerular Filtration is active and therefore nonsaturable

A

False, it is PASSIVE and nonsaturable

31
Q

How do we measure Glomerular Filtration Rate (GFR) clinically?
- overall what controls renal excretion?

A
  • Determining the Renal Clearance of Creatinine

- Renal Excretion is controlled by what happens in the tubules

32
Q

What type of molecules can be filtered OUT of the blood in the glomerulus?
- what can prevent drugs from getting filtered out?

A

Ions, Glucose, Peptides (not prots.) are easily filtered out

Being tightly bound to large molecules prevents plasma proteins from getting filtered out

33
Q

How must is filtrate is reabsorbed in the kidney tubules?

A

90% of filtrate

34
Q

What are the 3 principle parts of excretion in the kidney?

A
  1. Glomerular Filtration
  2. Tubular Secretion
  3. Tubular Reabsorption
35
Q

Where does tubular secretion happen?

  • what does this entail?
  • Is it passive or active?
A

Where:
Proximal Tubule

Processes:
- Water Reabsorption and Active Secretion or Weak Electrolytes (especially Acids)

Energy:
This is an Active process MDR2 pumps are required

***Lots of Drug removal and Ion removal happens here

36
Q

Where does tubular reabsorption happen?

  • what does this entail?
  • Passive or Active?
A

Where:
Distal Tubules

Processes:
- NONionized lipid soluble forms of weak acids and bases are Reabsorbed and Returned to general circulation

37
Q

Why is it favored for lipophilic substances to be absorbed in the distal tubule?

A
  • Water has been removed in proximal Tubule and Ions have been removed so there is a high concentration of lipid in the filtrate relative to a lower concentration in the surrounding tissue and it tends to flow out
38
Q

What is the pH dependence on weak electrolytes in the urine?

  • what drugs are removed by raising pH and which are removed by lowering it?
  • Is movement passive or active?
A

Low urine pH = Basic weak electrolyte removal

High urine pH = Acidic electrolyte removal

why:
- Basic electrolytes will become charged at Low pH and will not be able to diffuse

39
Q

For a drug that’s filtered but not secreted or reabsorbed what will be renal clearance be in normal subjects?

A

120 mL/min

**CLr = GFR

40
Q

How do you know if the drug shows net absorption?

A

CLr

41
Q

What can you assume if renal clearance is greater than 120 mL/min?

A

Tubular Secretion must be contributing to the process (CLr>GFR)

42
Q

What is equivalent of glomerular filtration in the liver?

- how does it work?

A
  • Biliary Secretion is the Equivalent of Glomerular Filtration

Drugs and Metabolites are actively Released along with bile acids and salts that are released into the digestive tract

43
Q

What is Enterohepatic cycling?

A

Drugs (or their metabolites) are released via biliary excretion from the liver and then they (or their active or inactive metabolites) will be reabsorbed while passing through the small intestine causing prolongation of the drug’s effect